These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
521 related items for PubMed ID: 11820413
1. The dilemma of suspicious urine cytology in patients being followed for bladder cancer. Raitanen MP, Aine R, Kylmälä T, Kallio J, Liukkonen T, Tammela T, Finnbladder Group. Ann Chir Gynaecol; 2001; 90(4):256-9. PubMed ID: 11820413 [Abstract] [Full Text] [Related]
2. Routine follow-up cystoscopy in detection of recurrence in patients being monitored for bladder cancer. Raitanen MP, Leppilahti M, Tuhkanen K, Forssel T, Nylund P, Tammela T, FinnBladder Group. Ann Chir Gynaecol; 2001; 90(4):261-5. PubMed ID: 11820414 [Abstract] [Full Text] [Related]
3. Suspicious urine cytology (class III) in patients with bladder cancer: should it be considered as negative or positive? Raitanen MP, Aine RA, Kaasinen ES, Liukkonen TJ, Kylmälä TM, Huhtala H, Tammela TL, Finnbladder Group. Scand J Urol Nephrol; 2002; 36(3):213-7. PubMed ID: 12201938 [Abstract] [Full Text] [Related]
4. [The BTA stat test in the follow-up for bladder cancer]. Gutiérrez Baños JL, Martín García B, de Diego Rodríguez E, Hernández Rodríguez R, Portillo Martín JA, Correas Gómez MA, del Valle Schaan JI, Roca Edreira A, Rado Velázquez MA. Arch Esp Urol; 1999 Oct; 52(8):856-61. PubMed ID: 10589117 [Abstract] [Full Text] [Related]
7. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma]. Fernández Gómez JM, García Rodríguez J, Escaf Barmadah S, Raigoso P, Rodríguez Martínez JJ, Allende MT, Casasola Chamorro J, Rodríguez Faba O, Martín Benito JL, Regadera Sejas FJ. Arch Esp Urol; 2002 Oct; 55(1):41-9. PubMed ID: 11957750 [Abstract] [Full Text] [Related]
8. [Comparative study of BTA stat test, NMP-22, and cytology in the diagnosis of bladder cancer]. Gutiérrez Baños JL, Rebollo Rodrigo MH, Antolín Juarez F, Martín García B, Hernández Rodríguez R, Portillo Martín JA, Correas Gómez MA, del Valle Schaan JI, Roca Edreira A, de Diego Rodríguez E, Radó Velázquez MA. Arch Esp Urol; 2000 Oct; 53(1):21-7. PubMed ID: 10730421 [Abstract] [Full Text] [Related]
10. [Usefulness of BTA Stat test (Bard) in the diagnosis of bladder cancer. Preliminary results and comparison with cytology and cystoscopy]. Gutiérrez Baños JL, Martín García B, Hernández Rodríguez R, Portillo Martín JA, Correas Gómez MA, del Valle Schaan JI, Roca Edreira A, Villanueva Peña A, Gutíerrez García R, De Diego Rodríguez E, Rado Velázquez MA. Arch Esp Urol; 1998 Oct; 51(8):778-82. PubMed ID: 9859583 [Abstract] [Full Text] [Related]
12. Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer. Kumar A, Kumar R, Gupta NP. Jpn J Clin Oncol; 2006 Mar; 36(3):172-5. PubMed ID: 16520358 [Abstract] [Full Text] [Related]
16. Four bladder tumor markers have a disappointingly low sensitivity for small size and low grade recurrence. Boman H, Hedelin H, Holmäng S. J Urol; 2002 Jan; 167(1):80-3. PubMed ID: 11743280 [Abstract] [Full Text] [Related]
18. [Bladder tumor antigen test versus urinary cytology in patients with bladder tumors]. Gregersen B, Mommsen S, Svanholm H. Ugeskr Laeger; 1999 Apr 05; 161(14):2071-3. PubMed ID: 10354792 [Abstract] [Full Text] [Related]
19. Comparison of screening methods in the detection of bladder cancer. Ramakumar S, Bhuiyan J, Besse JA, Roberts SG, Wollan PC, Blute ML, O'Kane DJ. J Urol; 1999 Feb 05; 161(2):388-94. PubMed ID: 9915409 [Abstract] [Full Text] [Related]
20. Human complement factor H related protein test for monitoring bladder cancer. Raitanen MP, Marttila T, Nurmi M, Ala-Opas M, Nieminen P, Aine R, Tammela TL, Finnbladder Group. J Urol; 2001 Feb 05; 165(2):374-7. PubMed ID: 11176376 [Abstract] [Full Text] [Related] Page: [Next] [New Search]